Stock A099190 I-SENS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings i-SENS, Inc.

Equities

A099190

KR7099190001

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 27/06/2024 am IST 		5-day change 1st Jan Change
18,770 KRW -0.05% Intraday chart for i-SENS, Inc. -2.90% -34.37%
13/05 I-SENS, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
30/04 I-SENS, Inc. announced that it has received KRW 50 billion in funding from NH Investment & Securities Co., Ltd., Atinum Investment Co., Ltd CI

Strengths

  • Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
  • The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

Weaknesses

  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • The company is in debt and has limited leeway for investment
  • The valuation of the company is particularly high given the cash flows generated by its activity.
  • The company is not the most generous with respect to shareholders' compensation.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
  • Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
  • The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
I-SENS, INC. Stock i-SENS, Inc.
-34.37% 37Cr -
SHOCKWAVE MEDICAL Stock Shockwave Medical
+75.69% 1.26TCr -
B-
MASIMO CORPORATION Stock Masimo Corporation
+12.09% 699.99Cr
C-
PENUMBRA, INC. Stock Penumbra, Inc.
-30.85% 677.69Cr
C+
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD. Stock Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
+9.17% 520.31Cr
D+
GETINGE AB Stock Getinge AB
-20.22% 467.11Cr
B
APT MEDICAL INC. Stock APT Medical Inc.
+16.71% 426.33Cr -
ASAHI INTECC CO., LTD. Stock Asahi Intecc Co., Ltd.
-21.04% 383.97Cr
B-
INARI MEDICAL, INC. Stock Inari Medical, Inc.
-27.63% 270.28Cr
C
SKAN GROUP AG Stock SKAN Group AG
-0.99% 197.69Cr -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. A099190 Stock
  4. Ratings i-SENS, Inc.